Search filters

List of works by Iolanda Lazaro

APOH is increased in the plasma and liver of type 2 diabetic patients with metabolic syndrome

scientific article published on 06 October 2009

Akt and ERK/Nrf2 activation by PUFA oxidation-derived aldehydes upregulates FABP4 expression in human macrophages.

scientific article published in August 2013

Effects of a Low Dose of Caffeine Alone or as Part of a Green Coffee Extract, in a Rat Dietary Model of Lean Non-Alcoholic Fatty Liver Disease without Inflammation

scientific article published on 23 October 2020

Ellagic Acid as a Tool to Limit the Diabetes Burden: Updated Evidence

scientific article published on 03 December 2020

FABP4 plasma levels are increased in familial combined hyperlipidemia.

scientific article

FABP4 predicts atherogenic dyslipidemia development. The PREDIMED study

article

Fatty acid binding protein 4 is increased in metabolic syndrome and with thiazolidinedione treatment in diabetic patients.

scientific article published on 5 June 2007

Fatty acid-binding protein 4 is associated with endothelial dysfunction in patients with type 2 diabetes

scientific article published on 27 July 2010

Fatty acid-binding protein-4 plasma levels are associated to metabolic abnormalities and response to therapy in girls and young women with androgen excess.

scientific article published on 24 May 2011

Gene Deficiency in Activating Fcγ Receptors Influences the Macrophage Phenotypic Balance and Reduces Atherosclerosis in Mice.

scientific article

Gene delivery of suppressors of cytokine signaling (SOCS) inhibits inflammation and atherosclerosis development in mice

scientific article published on 21 January 2015

Interplay between HSP90 and Nrf2 pathways in diabetes-associated atherosclerosis.

scientific article published on 7 February 2017

Lifestyle changes lower FABP4 plasma concentration in patients with cardiovascular risk

scientific article published on 05 December 2011

Mechanisms underlying the cardiometabolic protective effect of walnut consumption in obese people: A cross-over, randomized, double-blind, controlled inpatient physiology study

scientific article published on 02 July 2019

Nrf2 Activation Provides Atheroprotection in Diabetic Mice Through Concerted Upregulation of Antioxidant, Anti-inflammatory, and Autophagy Mechanisms

scientific article published on 31 July 2018

Parallel evolution of circulating FABP4 and NT-proBNP in heart failure patients.

scientific article published on 4 May 2013

Peptide inhibitor of NF-κB translocation ameliorates experimental atherosclerosis

scientific article published on 16 April 2013

Peptide-based inhibition of IκB kinase/nuclear factor-κB pathway protects against diabetes-associated nephropathy and atherosclerosis in a mouse model of type 1 diabetes.

scientific article

Plasma fatty acid binding protein 4 is associated with atherogenic dyslipidemia in diabetes

scientific article published on 17 April 2008

Retinol-binding protein 4 as a plasma biomarker of renal dysfunction and cardiovascular disease in type 2 diabetes

scientific article published on 01 October 2007

SOCS1-targeted therapy ameliorates renal and vascular oxidative stress in diabetes via STAT1 and PI3K inhibition

scientific article published on 14 March 2018

Short-term treatment with high dose liraglutide improves lipid and lipoprotein profile and changes hormonal mediators of lipid metabolism in obese patients with no overt type 2 diabetes mellitus: a randomized, placebo-controlled, cross-over, double-

scientific article published on 31 October 2019

Suppressor of Cytokine Signaling-1 Peptidomimetic Limits Progression of Diabetic Nephropathy.

scientific article

Suppressor of cytokine signaling 1-derived peptide inhibits Janus kinase/signal transducers and activators of transcription pathway and improves inflammation and atherosclerosis in diabetic mice.

scientific article

Targeting HSP90 Ameliorates Nephropathy and Atherosclerosis Through Suppression of NF-κB and STAT Signaling Pathways in Diabetic Mice

scientific article published on 26 June 2015

The APOA5-1131 T>C variant enhances the association between RBP4 and hypertriglyceridemia in diabetes.

scientific article published on 17 September 2009

The fatty acid binding protein-4 (FABP4) is a strong biomarker of metabolic syndrome and lipodystrophy in HIV-infected patients

article

Paulina is supported by:

About Paulina

Help